专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20120028983A1 NOVEL COMPOUND HAVING 3-HETEROARYLPYRIMIDIN-4-(3H)-ONE STRUCTURE AND PHARMACEUTICAL PREPARATION CONTAINING SAME 失效
标题翻译：具有3-叔丁基嘧啶-4-（3H） - 酮结构的新型化合物和含有它们的药物制备
公开(公告)号：US20120028983A1
公开(公告)日：2012-02-02
申请号：US13263023
申请日：2010-04-16
申请人： Toru Miura , Kazuhiro Onogi , Seiichi Sato , Junya Tagashira , Gen Watanabe , Ryohei Sekimoto , Rie Ishida , Hitomi Aoki , Tadaaki Ohgiya
发明人： Toru Miura , Kazuhiro Onogi , Seiichi Sato , Junya Tagashira , Gen Watanabe , Ryohei Sekimoto , Rie Ishida , Hitomi Aoki , Tadaaki Ohgiya
IPC分类号： A61K31/53 , C07D403/14 , C07D413/14 , C07D417/14 , A61P13/12 , A61P3/00 , A61P3/10 , A61P9/00 , A61P9/10 , A61P9/12 , C07D401/14 , A61K31/513
CPC分类号： C07D401/14 , C07D403/14 , C07D413/14 , C07D417/14
摘要： Disclosed is a compound which has both an angiotensin-II receptor antagonistic activity and a PPARγ activation activity and is useful as a prophylactic and/or therapeutic agent for hypertension, heart diseases, angina pectoris, cerebrovascular disorders, cerebral circulatory disorders, ischemic peripheral circulatory disorders, renal diseases, arteriosclerosis, inflammatory diseases, type-2 diabetes, diabetic complications, insulin resistance syndrome, syndrome X, metabolic syndrome and hyperinsulinemia. [In the formula, A represents a 5- to 10-membered heteroaryl group; R1 and R2 independently represent a C1-6 alkyl group; and each of R3 to R5 is absent or represents H, a halogen atom, OH, NO2, a halo-C1-6 alkyl group, a (substituted) C1-6 alkoxy group, a (substituted) C3-6 cycloalkyloxy group, or a 5- to 10-membered heteroaryl group.]
摘要翻译：公开了具有血管紧张素-II受体拮抗作用和PPARγ活化活性的化合物，可用作高血压，心脏病，心绞痛，脑血管病，脑循环障碍，缺血性外周循环障碍的预防和/或治疗剂肾脏疾病，动脉硬化，炎性疾病，2型糖尿病，糖尿病并发症，胰岛素抵抗综合征，X综合征，代谢综合征和高胰岛素血症。 [式中，A表示5至10元杂芳基; R1和R2独立地表示C1-6烷基; 并且R 3至R 5不存在或表示H，卤素原子，OH，NO 2，卤代C 1-6烷基，（取代的）C 1-6烷氧基，（取代的）C 3-6环烷氧基或 5至10元杂芳基。]

2. 发明申请

US20080270736A1 Information processing apparatus and access control method 有权
标题翻译：信息处理装置和访问控制方法
公开(公告)号：US20080270736A1
公开(公告)日：2008-10-30
申请号：US12075220
申请日：2008-03-10
申请人： Tsuyoshi Nishida , Gen Watanabe , Kazuyoshi Kuwahara , Hajime Sonobe
发明人： Tsuyoshi Nishida , Gen Watanabe , Kazuyoshi Kuwahara , Hajime Sonobe
IPC分类号： G06F12/08
CPC分类号： G06F12/08 , G06F9/30098 , G06F9/3824 , G06F9/3891
摘要： According to one embodiment, an information processing apparatus includes a processor including a register file which holds physical registers to which general purpose registers provided by an instruction set architecture are assigned, a virtual register assigning unit which assigns a virtual address in the main memory space to a physical register in the register file based on a request from a program, and records a correspondence between each of the virtual addresses and a corresponding one of the physical registers in a virtual register conversion table, and an access converting unit which determines whether or not a virtual address to be accessed is recorded in the virtual register conversion table managed by the virtual register assigning unit, and executes, when the virtual address is recorded therein, processing of accessing the physical register of which a correspondence to the virtual address is recorded in the virtual register conversion table.
摘要翻译：根据一个实施例，一种信息处理设备包括：处理器，包括：寄存器文件，其保存由指定集架构提供的通用寄存器被分配到的物理寄存器;虚拟寄存器分配单元，其将主存储器空间中的虚拟地址分配给基于来自程序的请求的寄存器文件中的物理寄存器，并且记录虚拟寄存器转换表中的每个虚拟地址和对应的一个物理寄存器之间的对应关系，以及访问转换单元，其确定是否要访问的虚拟地址被记录在由虚拟寄存器分配单元管理的虚拟寄存器转换表中，并且当虚拟地址被记录在其中时，执行访问与虚拟地址的对应关系的物理寄存器的处理被记录在虚拟寄存器转换表。

3. 发明申请

US20130102621A1 NOVEL CONDENSED PYRIDINE OR CONDENSED PYRIMIDINE DERIVATIVE, AND MEDICINAL AGENT COMPRISING SAME 有权
标题翻译：新型浓缩的吡啶或稠合的吡啶衍生物，以及包含其的药物
公开(公告)号：US20130102621A1
公开(公告)日：2013-04-25
申请号：US13806940
申请日：2011-06-24
申请人： Toshiharu Morimoto , Tomoaki Koshizawa , Gen Watanabe , Tadaaki Ohgiya , Nao Yamasaki , Noriyuki Inoue
发明人： Toshiharu Morimoto , Tomoaki Koshizawa , Gen Watanabe , Tadaaki Ohgiya , Nao Yamasaki , Noriyuki Inoue
IPC分类号： C07D491/048 , C07D487/04 , C07D495/04
CPC分类号： C07D491/048 , C07D487/04 , C07D495/04
摘要： The present invention relates to provision of a novel compound that has an activity of promoting insulin secretion from pancreatic β cells and thus is useful as a prophylaxis and/or therapeutic agent for diseases caused by hyperglycemia such as diabetes mellitus, andthe compound represented by the following formula (1): wherein one of A and B represents a nitrogen atom and the other represents a nitrogen atom or CR10, X represents an oxygen atom, a sulfur atom or —(CH2)n-N(R12)—, Y represents an oxygen atom, a sulfur atom or —N(R13)—, and R1 to R9 each represent a hydrogen atom or another substituent, or a salt thereof, or a solvate of the compound or the salt.
摘要翻译：本发明涉及提供具有促进胰β细胞胰岛素分泌的活性的新型化合物，因此可用作由高血糖引起的疾病如糖尿病的预防和/或治疗剂，以及由下式（1）：其中A和B之一表示氮原子，另一个表示氮原子或CR 10，X表示氧原子，硫原子或 - （CH 2）n N（R 12） - ，Y表示氧原子，硫原子或-N（R 13） - ，并且R 1至R 9各自表示氢原子或其它取代基，或其盐，或化合物或其盐的溶剂合物。

4. 发明申请

US20120303943A1 INFORMATION PROCESSING APPARATUS AND AUTHENTICATION CONTROL METHOD 审中-公开
标题翻译：信息处理设备和认证控制方法
公开(公告)号：US20120303943A1
公开(公告)日：2012-11-29
申请号：US13398628
申请日：2012-02-16
申请人： Satoshi Tamura , Toru Hanada , Isamu Uchiyama , Gen Watanabe
发明人： Satoshi Tamura , Toru Hanada , Isamu Uchiyama , Gen Watanabe
IPC分类号： G06F21/00
CPC分类号： G06F21/44 , G06F21/6218
摘要： According to one embodiment, a control module determines whether a second authentication key is present in a authentication key storage device when an information processing apparatus is powered on. The control module displays an identification code input screen for inputting an identification code if the second authentication key is not present, causes a storage device to execute an identification code authentication process of determining whether the identification code which is input to the identification code input screen agrees with the first identification code, and generates a third authentication key and stores the third authentication key in the authentication key storage device if the identification code authentication process is successfully carried out.
摘要翻译：根据一个实施例，当信息处理设备通电时，控制模块确定认证密钥存储设备中是否存在第二认证密钥。如果不存在第二认证密钥，则控制模块显示用于输入识别码的识别码输入画面，使存储装置执行识别码认证处理，以确定输入到识别码输入画面的识别码是否一致并且如果成功地执行了识别码认证处理，则生成第三认证密钥并将第三认证密钥存储在认证密钥存储装置中。

5. 发明申请

US20120004197A1 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR ANEMIA COMPRISING TETRAHYDROQUINOLINE COMPOUND AS ACTIVE INGREDIENT 有权
标题翻译：用于包含四氢喹啉化合物的抗坏血酸和/或治疗药物作为活性成分
公开(公告)号：US20120004197A1
公开(公告)日：2012-01-05
申请号：US13256549
申请日：2010-03-31
申请人： Masanori Ashikawa , Junya Tagashira , Akiyasu Koketsu , Toshiharu Morimoto , Takahiro Kitamura , Syunji Takemura , Gen Watanabe , Tatsuaki Nishiyama , Satoshi Goda , Masaki Yamabi , Takeshi Doi , Hiroyuki Ishiwata
发明人： Masanori Ashikawa , Junya Tagashira , Akiyasu Koketsu , Toshiharu Morimoto , Takahiro Kitamura , Syunji Takemura , Gen Watanabe , Tatsuaki Nishiyama , Satoshi Goda , Masaki Yamabi , Takeshi Doi , Hiroyuki Ishiwata
IPC分类号： A61K31/4706 , C07D413/12 , C07D215/14 , C07D215/233 , C07D401/12 , A61P7/06 , C07D413/14 , A61K31/5377 , A61K31/47 , A61K31/496 , A61K31/69 , C07D215/44 , C07F5/02
CPC分类号： C07D215/42 , A61K31/47 , A61K31/4706 , A61K31/4709 , A61K31/496 , A61K31/5377 , A61K31/69 , C07D215/233 , C07D215/44 , C07D215/46 , C07D215/48 , C07D401/04 , C07D401/12 , C07D405/12 , C07D413/04 , C07D413/12 , C07D417/12
摘要： Disclosed is a compound which has a low molecular weight and has an activity of enhancing the production of EPO and/or an activity of enhancing the production of hemoglobin. Specifically disclosed is and EPO production enhancer and/or a hemoglobin production enhancer comprising a 1-acyl-4-(substituted oxy, substituted amino, or substituted thio)-1,2,3,4-tetrahydroquinoline derivative, more specifically a tetrahydroquinoline compound represented by general formula (1) [wherein R1, R2, R2′, R3 and R3′ independently represent a hydrogen atom, a C1-6 alkyl group, or the like; R4, R5, R6, R7, R8, R9 and R10 independently represent a hydrogen atom, a halogen atom, a C1-6 alkyl group, or the like; A represents N—R11, a sulfur atom, or an oxygen atom; R11 represents a hydrogen atom, a C1-6 alkyl group, or the like; B represents a C6-14 aryl group, or a 5- to 10-membered heterocyclic group; and n represents an integer of 0 or 1], a salt of the tetrahydroquinoline compound, or a solvate of the tetrahydroquinoline compound or the salt.
摘要翻译：公开了具有低分子量且具有增强EPO产生活性和/或提高血红蛋白生成活性的化合物。具体公开的是EPO生产增强剂和/或包含1-酰基-4-（取代的氧基，取代的氨基或取代的硫代）-1,2,3,4-四氢喹啉衍生物，更具体地是四氢喹啉化合物的血红蛋白生成增强剂由通式（1）表示[其中R1，R2，R2'，R3和R3'独立地表示氢原子，C1-6烷基等; R 4，R 5，R 6，R 7，R 8，R 9和R 10独立地表示氢原子，卤素原子，C 1-6烷基等; A表示N-R11，硫原子或氧原子; R 11表示氢原子，C 1-6烷基等; B表示C 6-14芳基或5至10元杂环基; n表示0或1的整数]，四氢喹啉化合物的盐或四氢喹啉化合物或其盐的溶剂合物。

6. 发明申请

US20110296223A1 Electronic Apparatus and Control Method of the Electronic Apparatus 审中-公开
标题翻译：电子设备的电子设备和控制方法
公开(公告)号：US20110296223A1
公开(公告)日：2011-12-01
申请号：US13107098
申请日：2011-05-13
申请人： Gen Watanabe , Masayuki Sanada
发明人： Gen Watanabe , Masayuki Sanada
IPC分类号： G06F1/32
CPC分类号： G06F1/3203 , G06F1/3231 , G06F1/3265 , Y02D10/153 , Y02D10/173 , Y02D50/20
摘要： According to one embodiment, an electronic apparatus includes a display, an operating module, a power saving module, a sensor and a controller. The power saving module is configured to turn off a screen of the display when a non-operating period of the operating module reaches a reference period. The sensor is configured to detect a vibration. The controller is configured to change the reference period from a first value given as the initial value to a second value longer than the first value when the sensor detects a vibration.
摘要翻译：根据一个实施例，电子设备包括显示器，操作模块，省电模块，传感器和控制器。省电模块被配置为当操作模块的非操作周期达到参考周期时，关闭显示器的屏幕。传感器被配置为检测振动。控制器被配置为当传感器检测到振动时，将从基准周期的初始值改变为长于第一值的第二值。

7. 发明申请

US20080267256A1 INFORMATION PROCESSING APPARATUS AND CONTROL METHOD OF PROCESSOR CIRCUIT 审中-公开
标题翻译：信号处理装置和处理器电路的控制方法
公开(公告)号：US20080267256A1
公开(公告)日：2008-10-30
申请号：US12110230
申请日：2008-04-25
申请人： Gen Watanabe , Tsuyoshi Nishida , Kazuyoshi Kuwahara , Hajime Sonobe
发明人： Gen Watanabe , Tsuyoshi Nishida , Kazuyoshi Kuwahara , Hajime Sonobe
IPC分类号： G01K13/00
CPC分类号： G01K7/425
摘要： According to one embodiment, an information processing apparatus comprises a plurality of temperature transmission sections provided in each of first and second semiconductor circuits, and configure to transmit first measured temperature of one of the first and second semiconductor circuits to the other of first and second semiconductor circuits when the first measured temperature is higher than a threshold temperature, and a plurality of operation speed varying sections provided in each of the first and second semiconductor circuits configure to reduce operation speed of the processor circuit possessed by the other of first and second semiconductor circuits, when the received first measured temperature is higher than the second measured temperature of the other of the first and second semiconductor circuits.
摘要翻译：根据一个实施例，信息处理设备包括设置在第一和第二半导体电路中的每一个中的多个温度传输部分，并且被配置为将第一和第二半导体电路之一的第一测量温度传输到第一和第二半导体中的另一个第一测量温度高于阈值温度的电路，并且设置在第一和第二半导体电路中的每一个中的多个操作速度变化部分被配置为降低由第一和第二半导体电路中的另一个拥有的处理器电路的操作速度当接收的第一测量温度高于第一和第二半导体电路中的另一个的第二测量温度时。

8. 发明授权

US06954656B2 Information processing apparatus and network controller setting method 失效
标题翻译：信息处理设备和网络控制器设置方法
公开(公告)号：US06954656B2
公开(公告)日：2005-10-11
申请号：US09954033
申请日：2001-09-18
申请人： Gen Watanabe
发明人： Gen Watanabe
IPC分类号： G06F13/00 , H04L12/28 , H04W48/16 , H04W84/12 , H04W88/02 , H04W88/06 , H04M1/00
CPC分类号： H04L12/12 , H04W84/12 , H04W84/18 , H04W88/14 , Y02D50/40
摘要： There is provided a network controller setting method applied to an information processing apparatus with a plurality of network controllers. The method includes displaying a screen used to specify use/nonuse of each of the plurality of network controllers, and setting at least one of the plurality of network controllers, to which the use is not specified on the screen, in a disabled state. With this method, the unused network controllers can be brought reliably into the disabled state without letting the use have a sense of troublesomeness or imposing any burden on the user in setting a plurality of network controllers.
摘要翻译：提供了一种应用于具有多个网络控制器的信息处理设备的网络控制器设置方法。该方法包括显示用于指定多个网络控制器中的每一个的使用/不使用的屏幕，并且在禁用状态下将在屏幕上未指定使用的多个网络控制器中的至少一个设置为禁用状态。利用这种方法，可以使未使用的网络控制器可靠地进入禁用状态，而不会使用户对设置多个网络控制器具有麻烦感或对用户造成任何负担。

9. 发明授权

US08765771B2 Condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same 有权
标题翻译：缩合吡啶或稠合嘧啶衍生物，以及包含其的药剂
公开(公告)号：US08765771B2
公开(公告)日：2014-07-01
申请号：US13806940
申请日：2011-06-24
申请人： Toshiharu Morimoto , Tomoaki Koshizawa , Gen Watanabe , Tadaaki Ohgiya , Nao Yamasaki , Noriyuki Inoue
发明人： Toshiharu Morimoto , Tomoaki Koshizawa , Gen Watanabe , Tadaaki Ohgiya , Nao Yamasaki , Noriyuki Inoue
IPC分类号： A61K31/519 , C07D491/00
CPC分类号： C07D491/048 , C07D487/04 , C07D495/04
摘要： The present invention relates to provision of a novel compound that has an activity of promoting insulin secretion from pancreatic β cells and thus is useful as a prophylaxis and/or therapeutic agent for diseases caused by hyperglycemia such as diabetes mellitus, andthe compound represented by the following formula (1): wherein one of A and B represents a nitrogen atom and the other represents a nitrogen atom or CR10, X represents an oxygen atom, a sulfur atom or —(CH2)n-N(R12)—, Y represents an oxygen atom, a sulfur atom or —N(R13)—, and R1 to R9 each represent a hydrogen atom or another substituent, or a salt thereof, or a solvate of the compound or the salt.
摘要翻译：本发明涉及提供一种具有促进胰腺胰岛素分泌活性的新型化合物，细胞，因此可用作由高血糖引起的疾病如糖尿病的预防和/或治疗剂，以及由下式（1）表示的化合物：其中A和B之一表示氮原子，另一个表示氮原子或CR 10，X表示氧原子，硫原子或 - （CH 2）n N（R 12） - ，Y表示氧原子，硫原子或-N（R 13） - ，R 1〜原子或其它取代基，或其盐，或化合物或其盐的溶剂化物。

10. 发明申请

US20120322819A1 COMPOUND CONTAINING A NOVEL 4-ALKOXYPYRIMIDINE STRUCTURE AND MEDICINE CONTAINING SAME 审中-公开
标题翻译：含有新型4-烷氧基嘧啶结构的化合物和含有其的药物
公开(公告)号：US20120322819A1
公开(公告)日：2012-12-20
申请号：US13580056
申请日：2011-02-25
申请人： Toru Miura , Kazuhiro Onogi , Junya Tagashira , Gen Watanabe , Ryohei Sekimoto , Rie Ishida , Hitomi Aoki , Tadaaki Ohgiya
发明人： Toru Miura , Kazuhiro Onogi , Junya Tagashira , Gen Watanabe , Ryohei Sekimoto , Rie Ishida , Hitomi Aoki , Tadaaki Ohgiya
IPC分类号： A61K31/506 , C07D413/14 , A61P9/00 , A61P3/04 , A61P9/10 , A61P3/00 , A61P3/10 , C07D413/10 , A61P9/12
CPC分类号： C07D413/10 , C07D413/14
摘要： Disclosed is novel compound and medicinal formulation containing same, possessing both angiotensin II receptor blocking and PPARγ activation effect, of use as a medicine for prevention and/or treatment of hypertension, heart disease, angina pectoris, cerebrovascular disorder, cerebral circulatory disturbances, post-ischemic peripheral circulatory damage, renal disease, arteriosclerosis, inflammatory disorder, type 2 diabetes, diabetic complications, insulin resistance syndrome, syndrome X, metabolic syndrome and hyperinsulinaemia. Further disclosed is the general formula I (where one or both of R1 and R2 represent a C1-6 alkyl group, R3 represents a C1-6 alkyl group which may contain one or more substituent groups selected from group A, or a C3-8 cycloalkyl group which may contain one or more substituent groups selected from group B.) which represents the compound, and salts thereof, solvates thereof, and medicinal compositions containing any of these.
摘要翻译：公开了含有血管紧张素II受体阻断和PPARγ活化作用的新型化合物和药物制剂，用作预防和/或治疗高血压，心脏病，心绞痛，脑血管障碍，脑循环障碍，缺血性外周循环损伤，肾脏疾病，动脉硬化，炎性疾病，2型糖尿病，糖尿病并发症，胰岛素抵抗综合征，X综合征，代谢综合征和高胰岛素血症。进一步公开的是通式I（其中R 1和R 2中的一个或两个表示C 1-6烷基，R 3表示可以含有一个或多个选自A组的取代基的C 1-6烷基或C 3-8 可以含有一个或多个选自B组的取代基的环烷基），其代表该化合物及其盐，其溶剂合物，以及含有这些中的任何一种的药物组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式